题名 | TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt/beta-catenin signaling pathway |
作者 | |
发表日期 | 2020 |
发表期刊 | AMERICAN JOURNAL OF CANCER RESEARCH 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | TDP-43 HCC metastasis EMT GSK3 beta Wnt/beta-catenin signaling pathway GSK3β Wnt/β-catenin signaling pathway. |
其他关键词 | EPITHELIAL-MESENCHYMAL TRANSITION ; NUCLEAR FACTOR TDP-43 ; BETA-CATENIN ; BINDING-PROPERTIES ; CANCER METASTASIS ; RNA ; EXPRESSION ; PROTEIN ; MECHANISMS ; MUTATIONS |
摘要 | The trans-activation response DNA-binding protein of 43 kDa (TDP-43) is a nuclear protein that has been shown to be involved in the growth and metastasis of breast cancer, neuroblastoma, and melanoma. However, the effect of TDP-43 on hepatocellular carcinoma (HCC) metastasis remains unclear. Here, we demonstrated that TDP-43 was highly upregulated in both clinical samples and cell lines of HCC. Moreover, knockdown and overexpression of TDP-43 efficiently affected the proliferation and metastasis of HCC cells as well as the expression of some proteins associated with epithelial-mesenchymal transition (EMT) and Wnt/beta-catenin signaling pathway. Furthermore, activation of the Wnt/beta-catenin pathway by LiCI restored the effect of TDP-43 knockdown on EMT and HCC cells, whereas inhibition of the Wnt/beta-catenin pathway by XAV939 negated the effect of TDP-43 overexpression. Importantly, we found that TDP-43 protein could interact with GSK3 beta mRNA and regulate the level of GSK3 beta protein translation. Taken together, our findings suggest that TDP-43 may activate the Wnt/beta-catenin pathway by targeting the inhibition of GSK3 beta protein translation, thus inducing the proliferation and metastasis of HCC cells, which supports its potential value as a therapeutic target for the treatment of metastatic HCC. |
资助项目 | Major Science and Technology Plans for Medicine and Health of Zhejiang, China [WKJ-ZJ1723]; Major Science Technology Projects of Wenzhou, Zhejiang, China [2016Y0852]; Science and Technology projects of Zhejiang, China [LY18H160051]; Science and Technology Projects of Wenzhou, Zhejiang, China [Y20170001] |
出版者 | E-CENTURY PUBLISHING CORP |
出版地 | MADISON |
ISSN | 2156-6976 |
卷号 | 10期号:10页码:3285-3301 |
页数 | 17 |
WOS类目 | Oncology |
WOS研究方向 | Oncology |
WOS记录号 | WOS:000583897900013 |
收录类别 | SCIE ; PUBMED |
URL | 查看原文 |
PubMed ID | 33163270 |
PMC记录号 | PMC7642658 |
通讯作者地址 | [Shen, Zhifa]Wenzhou Med Univ, Inst Funct Nucle Acids & Personalized Canc Theran, Sch Lab Med & Life Sci, Key Lab Lab Med,Minist Educ,Zhejiang Prov Key Lab, Wenzhou 325035, Peoples R China. |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/1388 |
专题 | 检验医学院(生命科学学院、生物学实验教学中心) 附属第一医院 第一临床医学院(信息与工程学院)、附属第一医院_精准医学中心实验室 |
通讯作者 | Shen, Zhifa |
作者单位 | 1.Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Key Lab Lab Med,Minist Educ, Wenzhou 325035, Zhejiang, Peoples R China; 2.Wenzhou Med Univ, Affiliated Hosp 1, Precis Med Ctr Lab, Wenzhou 325000, Zhejiang, Peoples R China; 3.Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Di, Wenzhou 325000, Zhejiang, Peoples R China |
第一作者单位 | 检验医学院(生命科学学院、生物学实验教学中心); 第一临床医学院(信息与工程学院)、附属第一医院_精准医学中心实验室 |
通讯作者单位 | 温州医科大学 |
第一作者的第一单位 | 检验医学院(生命科学学院、生物学实验教学中心) |
推荐引用方式 GB/T 7714 | Guo, Feixia,Wang, Hongwei,Jiang, Min,et al. TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt/beta-catenin signaling pathway[J]. AMERICAN JOURNAL OF CANCER RESEARCH,2020,10(10):3285-3301. |
APA | Guo, Feixia., Wang, Hongwei., Jiang, Min., Yang, Qingguo., Xiang, Qi., ... & Shen, Zhifa. (2020). TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt/beta-catenin signaling pathway. AMERICAN JOURNAL OF CANCER RESEARCH, 10(10), 3285-3301. |
MLA | Guo, Feixia,et al."TDP-43 induces EMT and promotes hepatocellular carcinoma metastasis via activating Wnt/beta-catenin signaling pathway".AMERICAN JOURNAL OF CANCER RESEARCH 10.10(2020):3285-3301. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论